The dynamics of IL-6 in PTH treatment models are simplistic compared to multiple myeloma models. performs sensitivity analysis at a fixed time point rather than over time as in . Nonetheless, the results in support those in . Upon varying 11 parameter values from 50% to 150%, shows that bone volume is most sensitive to TGF-β and the progression of multiple myeloma disease is most sensitive to IL-6. Given these results